| A cyanobacterial photorespiratory bypass model to enhance photosynthesis by rerouting photorespiratory pathway in C3 plants G Khurshid, AZ Abbassi, MF Khalid, MN Gondal, TA Naqvi, MM Shah, ... Scientific Reports 10 (1), 20879, 2020 | 12 | 2020 |
| Navigating multi-scale cancer systems biology towards model-driven clinical oncology and its applications in personalized therapeutics MN Gondal, SU Chaudhary Frontiers in Oncology 11, 712505, 2021 | 7 | 2021 |
| A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal … MN Gondal, RN Butt, OS Shah, MU Sultan, G Mustafa, Z Nasir, R Hussain, ... Frontiers in Oncology 11, 692592, 2021 | 7 | 2021 |
| Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy Y Bao, Y Qiao, JE Choi, Y Zhang, R Mannan, C Cheng, T He, Y Zheng, ... Proceedings of the National Academy of Sciences 120 (49), e2314416120, 2023 | 5 | 2023 |
| TISON: a next-generation multi-scale modeling theatre for in silico systems oncology MN Gondal, MU Sultan, A Arif, A Rehman, HA Awan, Z Arshad, W Ahmed, ... BioRxiv, 2021.05. 04.442539, 2021 | 5 | 2021 |
| In silico Drosophila Patient Model Reveals Optimal Combinatorial Therapies for Colorectal Cancer MN Gondal, RN Butt, OS Shah, Z Nasir, R Hussain, H Khawar, M Tariq, ... bioRxiv, 2020.08. 31.274829, 2020 | 2 | 2020 |
| Pan-tissue master regulator inference reveals mechanisms of MHC alterations in cancers MN Gondal, R Mannan, Y Bao, J Hu, M Cieslik, AM Chinnaiyan Cancer Research 84 (6_Supplement), 860-860, 2024 | 1 | 2024 |
| PIKfyve controls dendritic cell function and tumor immunity JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ... bioRxiv, 2024 | 1 | 2024 |
| Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients MN Gondal, M Cieslik, AM Chinnaiyan bioRxiv, 2024 | 1 | 2024 |
| Navigating Multi-scale Cancer Systems Biology towards Model-driven Personalized Therapeutics MN Gondal, SU Chaudhary bioRxiv, 2021.05. 17.444410, 2021 | 1 | 2021 |
| PIKfyve, expressed by CD11c-positive cells, controls tumor immunity JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ... Nature Communications 15 (1), 5487, 2024 | | 2024 |
| A Systematic Overview of Single-Cell Transcriptomics Databases, their Use cases, and Limitations MN Gondal, SUR Shah, AM Chinnaiyan, M Cieslik ArXiv, 2024 | | 2024 |
| Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy P Borker, Y Bao, Y Qiao, A Chinnaiyan, JE Choi, Y Zhang, R Mannan, ... Cancer Research 84 (6_Supplement), 7479-7479, 2024 | | 2024 |
| CanSeer: A Method for Development and Clinical Translation of Personalized Cancer Therapeutics RN Butt, B Amina, MU Sultan, ZB Tanveer, R Hussain, R Akbar, S Khan, ... bioRxiv, 2022.06. 29.498138, 2022 | | 2022 |
| A Personalized Therapeutics Approach Using an In Silico MN Gondal, RN Butt, OS Shah, MU Sultan, G Mustafa, Z Nasir, R Hussain, ... Combinatorial Approaches for Cancer Treatment: from Basic to Translational …, 2022 | | 2022 |
Safee Ullah ChaudharyBiomedical Informatics & Engineering Research Laboratory, Lahore University of Management Sciences在 lums.edu.pk 的电子邮件经过验证
